<SEC-DOCUMENT>0001104659-23-088387-index.html : 20230807 <SEC-HEADER>0001104659-23-088387.hdr.sgml : 20230807 <ACCEPTANCE-DATETIME>20230807164114 ACCESSION NUMBER: 0001104659-23-088387 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 EFFECTIVENESS DATE: 20230807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Astria Therapeutics, Inc. CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-273773 FILM NUMBER: 231148137 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090127 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2322563d1_s8.htm <DESCRIPTION>FORM S-8 <TEXT> Document 1 - file: tm2322563d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2322563d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2322563d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>tm2322563d1_ex23-2.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 3 - file: tm2322563d1_ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tm2322563d1_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tm2322563d1_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2322563d1_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2322563d1_ex5-1img001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm2322563d1_ex5-1img002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm2322563d1_ex5-1img002.jpg
</DOCUMENT> </SEC-DOCUMENT>